Table 4.
Demographic characteristics in the G-MADS and G-noMADS groups before and after propensity score matching procedure.
| Before PSM (crude data) |
After PSM |
|||||
|---|---|---|---|---|---|---|
| G-MADS | G-noMADS | P-value | G-MADS | G-noMADS | P-value | |
| n | 197 | 734 | 175 | 175 | ||
| Female (%) | 166 (84.3) | 636 (87.4) | 0.12 | 148 (84.6) | 154 (87.9) | 0.15 |
| Age (yr, mean ± SD) | 81.9 ± 8.5 | 77.7 ± 10.9 | < 0.001 | 82.0 ± 8.4 | 81.1 ± 8.4 | 0.14 |
| Prevalent VF (%) | 147 (74.6) | 425 (9.7) | < 0.001 | 132 (75.3) | 117 (69.6) | 0.09 |
| Prevalent NVF (%) | 29 (14.7) | 71 (9.7) | < 0.05 | 25 (14.3) | 27 (15.4) | 0.75 |
| Current smoking (%) | 9 (4.6) | 16 (2.2) | < 0.05 | 8 (4.4) | 10 (5.7) | 0.32 |
| Alcohol (%) | 4 (2.0) | 10 (1.4) | 0.25 | 4 (2.3) | 4 (2.3) | 1.00 |
| DM (%) | 69 (35.0) | 135 (18.4) | < 0.001 | 61 (34.8) | 71 (40.7) | 0.11 |
| COPD (%) | 34 (17.3) | 45 (6.1) | < 0.001 | 30 (17.0) | 33 (18.9) | 0.32 |
| Insomnia (%) | 79 (40.1) | 118 (16.1) | < 0.001 | 76 (43.4) | 86 (49.1) | 0.18 |
| HT (%) | 155 (78.7) | 313 (42.6) | < 0.001 | 136 (77.7) | 138 (78.9) | 0.39 |
| HL (%) | 74 (37.6) | 173 (23.6) | < 0.001 | 67 (38.3) | 66 (37.7) | 0.67 |
| CKD ≥ Stage 2 (%) | 85 (43.1) | 272 (37.1) | 0.13 | 80 (45.7) | 74 (42.3) | 0.45 |
| CD (%) | 73 (37.1) | 73 (9.9) | < 0.001 | 64 (36.6) | 69 (39.4) | 0.35 |
| RA (%) | 44 (22.3) | 240 (32.7) | < 0.01 | 39 (22.3) | 38 (21.7) | 0.80 |
| OA (%) | 129 (65.5) | 399 (54.4) | < 0.01 | 115 (65.7) | 109 (62.3) | 0.31 |
| Disuse (%) | 42 (21.3) | 23 (3.1) | < 0.001 | 27 (15.4) | 18 (10.3) | 0.11 |
| Contracture (%) | 37 (18.8) | 54 (7.4) | < 0.001 | 31 (17.7) | 24 (13.7) | 0.13 |
| Parkinsonism (%) | 17 (8.6) | 8 (1.1) | < 0.001 | 10 (5.7) | 7 (4.0) | 0.23 |
| T-score in the LS < −2.5 (%) | 105 (53.3) | 335 (45.6) | 0.08 | 89 (50.9) | 87 (49.7) | 0.83 |
| T-score in the FN < −2.5 (%) | 99 (50.3) | 243 (33.1) | < 0.001 | 85 (48.6) | 82 (46.9) | 0.83 |
| GCS administrated (%) | 40 (20.3) | 128 (17.4) | 0.18 | 37 (21.1) | 46 (26.3) | 0.12 |
| OPD administrated (%) | 69 (35.0) | 143 (19.5) | < 0.001 | 62 (35.4) | 50 (28.6) | 0.08 |
| VD supplemented (%) | 112 (56.9) | 435 (59.3) | 0.26 | 102 (58.3) | 116 (66.3) | 0.06 |
| BMI (mean ± S.D.) | 21.6 ± 3.2 | 22.7 ± 4.0 | 0.09 | 21.6 ± 3.3 | 21.6 ± 4.2 | 0.39 |
PSM, propensity score matching; G-MADS, Group with musculoskeletal ambulation disorder symptom complex. G-noMADS, Group without musculoskeletal ambulation disorder symptom complex. VF, vertebral body fracture; NVF, non-vertebral body fracture; DM, diabetes mellitus; COPD, chronic obstructive pulmonary diseases; HT, hypertension; HL, hyperlipidemia; CKD, chronic kidney disease; CD, cognitive disorders; RA, rheumatoid arthritis; OA, osteoarthritis; LS, lumbar spine; FN, femoral neck; GCS, glucocorticoid steroid; OPD, anti-osteoporosis drug; VD, vitamin-D; BMI, body mass index. Chi-square test for binary numbers and Mann-Whitney U test for mean age and BMI. Bold style are demonstrated as P-value within 5%.